6533b831fe1ef96bd1298e6d
RESEARCH PRODUCT
Antitumoral compounds from vertebrate sister group: A review of Mediterranean ascidians
Valentina LazzaraVincenzo ArizzaManuela MauroMirella VazzanaDiletta Punginellisubject
Mediterranean climateImmunologyPopulationBiodiversitySettore BIO/05 - ZoologiaZoologyAntineoplastic AgentsDrug developmentBiologyPeptides Cyclic01 natural sciencesAntitumoralchemistry.chemical_compoundDepsipeptidesNeoplasmsbiology.animalMediterranean SeaAnimalsHumansUrochordataInvertebrateSettore BIO/06 - Anatomia Comparata E CitologiaeducationCancerBiological Productseducation.field_of_study010405 organic chemistryfungiVertebrateBioactive compound0104 chemical sciencesMarine biodiversity010404 medicinal & biomolecular chemistryDrug developmentchemistrySister groupTunicatesBioactive compoundTrabectedinDevelopmental Biologydescription
Among the diseases that afflict the human population, cancer is one for which many drug treatments are not yet known or effective. Moreover, the pharmacological treatments used often create serious side effects in sick patients and for this reason, it is essential to find effective and less harmful treatments. To date, marine biodiversity is a real source of metabolites with antitumoral activity and among invertebrates' ascidians have been the main source to obtain them. Mediterranean area is the richest in biodiversity and contains several ascidian species used in drugs development during the years. However, many more Mediterranean ascidian species have not been studied and could be a source of useful bioactive compounds. This review aims to summarize the scientific studies that analyzed the antitumor compounds obtained from different Mediterranean ascidians species, encouraging them to search further compounds in other new species to improve pharmacological treatments and human population life.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-07-01 |